PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

tranylcypromine

Verify with FDA → · CMS NADAC pricing →

Brand names: Parnate

Monoamine Oxidase Inhibitor (MAOI) Rx

Tranylcypromine (Parnate) is a medicine used to treat major depression in adults. It is used when other antidepressants have not worked well enough.

Drug Shortage Alert

tranylcypromine is currently listed as to be discontinued by the FDA. Affected manufacturer: Teva Pharmaceuticals USA, Inc..

View all drug shortages →

Drug Pricing (NADAC)

Generic Price

$0.70/unit

Generic Available

Yes (3 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Tranylcypromine is used to treat major depressive disorder (MDD) in adults.

Common side effects

Dry mouth, Dizziness, Trouble sleeping

Key warnings

Tranylcypromine can increase the risk of suicidal thoughts and behaviors in young adults.

How It Works

Tranylcypromine belongs to a class of drugs called MAO inhibitors. It works by increasing the levels of certain chemicals in your brain. These chemicals can help improve your mood.

How to Take It

Take tranylcypromine by mouth. The usual starting dose is 30 mg per day, divided into smaller doses. If needed, your doctor may increase the dose by 10 mg every 1 to 3 weeks. The maximum dose is 60 mg per day, divided into two doses.

Pregnancy & Breastfeeding

There is limited information about the safety of tranylcypromine during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not recommended to breastfeed while taking this medicine because it can harm the baby.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store tranylcypromine at room temperature, between 59° and 86°F (15° and 30°C), in a tightly closed, light-resistant container.

Side Effects (from patient reports)

Based on 302 FDA adverse event reports.

Interaction between medicines
68
Feeling sad or hopeless
36
Medicine not working
31
Too much serotonin in the body
27
Head pain
24
High blood pressure
24
Thoughts of suicide
24
Heart defect
23
Dangerous increase in blood pressure
23
Taking a medicine you shouldn't
22

FDA Adverse Event Report Analysis

Detailed analysis of 329 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

329

Death-Related Reports

49

Hospitalization Reports

116

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 170 (63%)
Male 95 (35%)

Age Distribution

0–17 3
18–44 58
45–64 86
65–74 40
75+ 34

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INTERACTION 68
2 DEPRESSION 36
3 DRUG INEFFECTIVE 31
4 SEROTONIN SYNDROME 27
5 HEADACHE 24
6 HYPERTENSION 24
7 SUICIDAL IDEATION 24
8 ATRIOVENTRICULAR SEPTAL DEFECT 23
9 HYPERTENSIVE CRISIS 23
10 CONTRAINDICATED PRODUCT ADMINISTERED 22
11 DYSMORPHISM 22
12 HYPERHIDROSIS 22
13 MUSCLE SPASMS 21
14 INSOMNIA 20
15 NAUSEA 20

Reactions in Death Reports

COMPLETED SUICIDE 18
DYSMORPHISM 12
ATRIOVENTRICULAR SEPTAL DEFECT 11
FOETAL EXPOSURE DURING PREGNANCY 10
DRUG INTERACTION 9
FOETAL DEATH 8
HYPERTHERMIA 7
SEROTONIN SYNDROME 7
TOXICITY TO VARIOUS AGENTS 7
HYPERTELORISM OF ORBIT 6

Reactions in Hospitalization Reports

DRUG INTERACTION 20
DEPRESSION 18
OFF LABEL USE 15
SEROTONIN SYNDROME 14
HYPERTENSION 13
HYPERTENSIVE CRISIS 13
BLOOD PRESSURE FLUCTUATION 12
CONTRAINDICATED PRODUCT ADMINISTERED 11
DRUG INEFFECTIVE 11
OVERDOSE 11

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Tranylcypromine can increase the risk of suicidal thoughts and behaviors in young adults. It can also cause a dangerous increase in blood pressure if you eat foods high in tyramine or take certain medicines. Make sure to follow all food and drug restrictions.

Known Drug Interactions

Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...

Mechanism: These two antidepressants can cause a severe reaction when used at the same time. They both change brain chemicals in a way that can lead to dangerously high blood pressure.

What to do: Do not take these medications together. You must wait a specific amount of time when switching between these drugs to avoid serious side effects.

If in the absence of therapeutic alternatives and emergency treatment with a contraindicated drug (e.g., linezolid, intravenous methylene blue, direct-acting sympathomimetic drugs such as epinephrine) becomes necessary and cannot be delayed, discontinue tranylcypromine tablets as soon as possible before initiating treatment with the other agent, and monitor closely for adverse reactions. Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depress...

Mechanism: Both drugs act as MAO inhibitors, and using them together can cause a toxic buildup of chemicals in the brain. This can lead to a medical emergency with very high blood pressure.

What to do: Avoid this combination unless it is an emergency and no other options exist. If used together, you must stop tranylcypromine and be monitored very closely by medical staff.

Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...

Mechanism: Both drugs increase serotonin levels in the brain, which can lead to a dangerous and life-threatening condition called serotonin syndrome.

What to do: Do not take these medications together. Your doctor will typically require a waiting period of at least 14 days when switching between them.

If in the absence of therapeutic alternatives and emergency treatment with a contraindicated drug (e.g., linezolid, intravenous methylene blue, direct-acting sympathomimetic drugs such as epinephrine) becomes necessary and cannot be delayed, discontinue tranylcypromine tablets as soon as possible before initiating treatment with the other agent, and monitor closely for adverse reactions. Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depress...

Mechanism: Tranylcypromine prevents the body from breaking down epinephrine, which can cause a sudden and dangerously high spike in blood pressure.

What to do: Avoid this combination unless it is a medical emergency. If used in an emergency, a doctor must monitor your blood pressure and heart rate very closely.

Excessive reduction of blood glucose (additive effect) [See Warnings and Precautions (5.14)] ; CNS depressant agents (including opioids, alcohol, sedatives, hypnotics) Use with caution Increased CNS depression Dietary supplements containing sympathomimetics Contraindicated Antidepressants including but not limited to: • Other MAOIs (e.g., linezolid, intravenous methylene blue, selective MAOIs) • Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) • Tricyclic antidepressants • Amoxapine, bupropion, maprotiline, nefazodone, trazodone, v...

Mechanism: This combination stops the body from clearing norepinephrine, which can cause blood pressure to rise to levels that may cause a stroke or heart attack.

What to do: Avoid using these drugs at the same time. If they must be used in a hospital setting, your vital signs must be monitored constantly by medical staff.

Check all your medications →

Common Questions

Can I start tranylcypromine right after stopping another antidepressant?
No, you need to wait a certain amount of time. This could be from 1 week to 5 weeks, depending on the other antidepressant. Talk to your doctor.
What foods should I avoid while taking tranylcypromine?
You should avoid foods high in tyramine, such as aged cheeses, cured meats, and fermented foods.
Can I take over-the-counter medicines with tranylcypromine?
You should talk to your doctor or pharmacist before taking any over-the-counter medicines or supplements.
What should I do if I experience a severe headache while taking tranylcypromine?
A severe headache could be a sign of a hypertensive crisis. Seek immediate medical attention.
Can tranylcypromine cause problems if I need surgery?
Yes, it can affect your blood pressure during surgery. If possible, stop taking tranylcypromine before elective surgery.
Will this medicine make me gain weight?
Weight gain is a possible side effect, but significant anorexia (loss of appetite) is also possible.
Can I drink alcohol while taking tranylcypromine?
You should avoid alcohol, as it can interact with tranylcypromine and cause dangerous side effects.
What are the signs of a hypertensive crisis?
Signs include severe headache, stiff neck, nausea, vomiting, sweating, and very high blood pressure.
Is tranylcypromine safe for children and teenagers?
No, tranylcypromine is not approved for use in children and teenagers.
What should I do if I feel my depression is getting worse?
Tell your doctor right away if you feel your depression is getting worse or if you have thoughts of harming yourself.
What are the common side effects of tranylcypromine?
The most commonly reported side effects of tranylcypromine include Dry mouth, Dizziness, Trouble sleeping, Feeling sleepy, Headache. Based on 302 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does tranylcypromine interact with other medications?
Yes, tranylcypromine has 42 known drug interactions. Notable interactions include bupropion, linezolid, vilazodone. Always inform your doctor about all medications you are taking.
What drug class is tranylcypromine?
tranylcypromine belongs to the Monoamine Oxidase Inhibitor (MAOI) drug class. It requires a prescription (Rx). Tranylcypromine is used to treat major depressive disorder (MDD) in adults.
Is tranylcypromine safe during pregnancy?
There is limited information about the safety of tranylcypromine during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Is tranylcypromine currently in shortage?
Yes, tranylcypromine is currently listed as to be discontinued by the FDA. Affected manufacturer: Teva Pharmaceuticals USA, Inc.. Visit the FDA Drug Shortages database for the latest updates.

Related Medications in Monoamine Oxidase Inhibitor (MAOI)

Other drugs grouped near tranylcypromine — same-class peers and common alternatives.

Compare tranylcypromine vs acamprosate side-by-side →

Medication Guides

Related Health & Safety Data

Save on tranylcypromine

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for tranylcypromine

The FDA label for tranylcypromine (sold under brand names such as Parnate) classifies it as a prescription-only medication in the Monoamine Oxidase Inhibitor (MAOI) class. Tranylcypromine is used to treat major depressive disorder (MDD) in adults. Official labeling lists 9 commonly reported side effects, including Dry mouth, Dizziness, Trouble sleeping.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 302 voluntary reports. The database also lists 42 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.70.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: December 20, 2024

All federal data sources used on this page